Clinical trial
Aripiprazole to Reduce Cocaine Relapse
NCT00276874 · Craig Rush, Other · Completed
Key facts
| NCT number | NCT00276874 |
|---|---|
| Title | Aripiprazole to Reduce Cocaine Relapse |
| Official title | Preventing Cocaine Relapse: Developing Pharmacotherapies |
| Lead sponsor | Craig Rush, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Aripiprazole, Placebos |
| Enrollment | 41 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2012 |
| Completion | Jan 1, 2012 |
| First posted | Jan 13, 2006 |
| Last update posted | Apr 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: